SIGN UP NOW for our Oct. 24^th webinar! Despite the use of effective drug and device therapies, many patients with HFrEF continue to experience worsening symptoms and disease progression. Barostim is a novel device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Patients feel better and their quality of life improves.

Lesion-specific physiology matters! Three leading experts review cases that demonstrate why and how lesion-specific physiology can inform treatment for patients with CAD and lessons learned from 10 years of FFR_CT interpretation.

We need to change the conversation on women, chest pain and coronary artery disease (CAD). Two leading experts will review women’s unique biology, risk factors, and presenting symptoms of heart disease during this webinar. They also will discuss better ways to detect and diagnose CAD, and how cardiac CT and FFR_CT can identify those at-risk and in need of treatment. Join us to learn how cardiovascular (CV) teams can identify women at risk of CAD who are most likely to benefit from further testing and treatment.

Philips is using its remote ECG monitoring technology to help providers transform how healthcare is delivered to improve patient care. So that means delivering timely, actionable patient data insights to accelerate clinical decisions and streamline workflows inside and outside the hospital in one location to better monitor patients.

Four leading physicians in intracardiac echocardiography talk about the milestones achieved with ACUSON AcuNav 2D and 4D intracardiac echo catheters over the last 24 years.